CASSIDY HILL: Open Payments
NPI 1144981077 · REHOBOTH BEACH, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,042 in 31 payments from 10 companies in 2025. Trend: 2023 $572 · 2024 $326 · 2025 $1,042
Food & beverage: $976Education: $66
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $358 |
| UCB, Inc. | 3 | $207 |
| Lilly USA, LLC | 1 | $125 |
| ABBVIE INC. | 5 | $110 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| Genentech USA, Inc. | 2 | $62 |
| PFIZER INC. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Incyte Corporation | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
Products named: TREMFYA, Bimzelx, EBGLYSS, SKYRIZI, Xolair, Rhapsido, CIBINQO, RINVOQ.
Industry payments across DE — which companies pay providers there.
